A novel home fertility test which is said to be 99% accurate is the latest project to seek investment via Cambridge crowd-funding platform SyndicateRoom.
Backers can put their cash into Fertility Focus’s device OvuSense, which uses real-time ovulation monitoring to take the guesswork out of when to try for a baby. It is unique in being able to precisely predict the onset of ovulation a day in advance and confirm the exact time and date when it occurs.
The company is seeking £275,000 to accelerate the launch of its next generation OvuSense product at a much lower price point and extend international sales and marketing for its e-commerce platform, which provides a range of resources for women trying to get pregnant. It plans to look for a further £1m next year.
The company predicts an impressive exit value in excess of £60m from a current valuation of £4m.
Read the full article here.